| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |